Health

Instructions for use of the drug Belara, reviews of women and doctors

Pin
Send
Share
Send
Send


The article will consider the instructions for use and reviews of "Belara".

This is a mixed oral contraceptive. Prolonged use of the drug leads to a decrease in the secretion of follicle-stimulating hormone and luteinizing hormone, and, consequently, to suppress the process of ovulation. At the same time, proliferation and secretory transformation of the endometrium take place, which prevent the fertilized egg from fixing. Viscosity of mucous secretions from the cervix increases, which makes it difficult for male germ cells to pass through the cervical canal and inhibits their mobility.

Composition and release form

"Belara" is produced by the manufacturer in only one pharmacological form - in the form of tablets. They have a film coating, their color is pale pink, the shape is rounded. On a break, the tablet has a white color, or almost white.

Each tablet contraceptive contains 30 μg of ethinestradiol, 2 mg of chlormadinone acetate. In addition, in the manufacture of the medicament, such excipients as magnesium stearate, lactose monohydrate, corn starch and povidone K30 are used. The film shell is made of titanium dioxide, propylene glycol, lactose monohydrate, dye, talc, macrogol 6000, hypromellose.

Tablets are located on a blister of 21 pieces. Each cardboard box contains 1 blister. In the reviews about "Belara" women note that it is convenient to take the drug.

Drug action

The drug is a composite contraceptive drug. With prolonged, longer than 3 weeks, taking the drug is the oppression of ovulation. In parallel with this, there is a change in the quality of cervical mucus, which complicates the penetration of sperm through the cervical canal, and also provokes the development of the pathology of their movement.

To inhibit ovulation, the required daily dosage of chlormadinone is 1.7 mg. The required dose per full cycle should be 25 mg. Under the influence of ethinyl estradiol, globulin increases significantly, reducing testosterone levels in the blood. Capable of producing endometrial proliferation.

In the reviews about Belara, women note that, in addition to the contraceptive effect, the remedy improves the menstrual cycle, reduces the pain of menstruation, the functionality of cystic formations in the ovaries, cancer of the ovaries and endometrium, diseases of the genital system.

Contraindications to receive

Belar should not be used if:

  1. There are thrombosis diseases, thromboembolism, primary symptoms of thrombophlebitis.
  2. An operation is assumed, or the body is in recovery from injuries.
  3. The patient is diagnosed with diabetes.
  4. There is a significant increase in blood pressure, uncontrolled arterial hypertension.
  5. There is an acquired or inherited predisposition to the development of diseases of the arteries and veins, including thrombosis, narrowing or varicose veins.
  6. Observed exacerbations of liver disease, chronic liver disease.
  7. Cholestasis or general irritation is noted, especially in the pre-pregnancy period.
  8. There are formations in the liver of a malignant character.
  9. Diagnosed diseases such as pathology of the withdrawal of bile, hereditary hepatosis, pigmentary hepatosis, enzymopathic jaundice.
  10. There are painful sensations in the peritoneum, the size of the liver is increased, there are signs of bleeding in the abdominal cavity.
  11. There are oncological diseases that are dependent on hormone therapy.
  12. There is a susceptibility to any component of the drug.
  13. Woman breastfeeding.
  14. A woman is pregnant or assumes that she is pregnant.
  15. The woman has bleeding from the vagina, the etymology of which is not clear.
  16. Marked growth of the endometrium.
  17. There is no menstruation, and the cause of this phenomenon is not determined.
  18. The woman is depressed.
  19. There are motor disorders, for example, paresis.
  20. There are critical pathologies of vision or hearing.
  21. A history of marked pancreatitis.

Reviews of tablets "Belara" consider below.

Instructions for admission

Tablets "Belary" are intended for oral administration, which is recommended to produce in the same period. Begin reception should be on the first day of the menstrual cycle. Tablets are taken one for 21 days. At the end of the course, you must take a break of 7 days. In this period should come menstruation. On the first day of its occurrence, the next course of taking Belara should begin.

It is necessary to swallow a tablet entirely, without chewing and without crushing, it is necessary to drink with a small amount of liquid. The blister has a label that will help not to get lost in taking pills.

If in the previous menstrual cycle no contraceptive medicine was used, then it is necessary to start taking Belara from the first day of the new cycle. At the onset of menstruation earlier than expected (more than 5 days), it is recommended to postpone the beginning of the course of the drug to the next menstrual cycle.

If you are switching to another oral contraceptive, which includes taking 21 pills, you should take the last pill of the course and immediately begin to take a new drug. That is, there should be no break between courses.

If the previous oral contraceptive included 28 pills, then taking the new package should be started in a similar way - the next day after taking the last pill of the previous product.

According to the reviews, contraceptive "Belara" is suitable for many women.

If you make the transition to "Belar" with a mini-drink, then you can start drinking tablets on any day, without a pause. When switching to an oral contraceptive after using an implant, you should take the first pill on the day it is removed. If a transition is made from contraceptives in an injection form, the first pill should be taken on the day of the last injection. Each of the described transitions should be accompanied by additional barrier contraception throughout the week.

After an abortion at an early date, you should start taking Belara immediately after it. Barrier contraception in this case may not be used.

After an abortion in late periods, or after childbirth, women who are not breastfeeding can begin to take Belu after a month. Additional contraception in this case is also not required. If during the postpartum period, but before taking the drug, the woman had sexual contact, she should wait until the onset of menstruation to eliminate the possibility of pregnancy, and then start taking oral contraceptive.

Adverse effects

According to the reviews to Belare, various undesirable reactions from various organs and systems can occur on the background of reception:

  1. Allergic reactions on the skin and rare manifestations of high sensitivity to the components of the drug from the immune system.
  2. Changes in the lipid composition of blood, increased appetite from the metabolism.
  3. Decrease in libido, irritability, depressed mental state on the part of the psyche.
  4. Headaches, dizziness from the NA.
  5. Hearing loss, conjunctivitis, visual impairment of the organs of sight.
  6. Thrombophlebitis, arterial hypertension, varices of the cardiovascular system.
  7. Abdominal distention and stool disorders, infrequent abdominal pain, frequent nausea and vomiting of the gastrointestinal tract.
  8. Exacerbation of psoriasis, if present, urticaria, sweating, hair loss, acne on the face of the skin.
  9. Weight gain, swelling, general fatigue.
  10. The increase in the intensity of vaginal discharge, delayed menstruation.

This is confirmed by the tool "Belara" instruction and reviews.

The average price of Belaia in pharmacies in Russia fluctuates at 500 rubles for a package containing 21 tablets, and 750 rubles for a package containing 63 tablets. The price is considered quite acceptable.

Drugs with the same "Belare" composition today does not exist. However, drugstores present drugs that are similar to Belara in their hormonal components and have a similar effect. These include "Klimene", "Evra", "Demoulin", "Ginodian Depot", "Anteovin".

Reviews of doctors about "Belara" are presented below.

Pros and cons of the drug

Reviews of doctors about the pros and cons of "Belara" are also available. Doctors gynecologists indicate that "Belara" has established itself as an effective and high-quality contraceptive. If you take the medication in full accordance with the recommendations of the doctor, as well as adhere to the advice noted in the instructions, the occurrence of an unplanned pregnancy is excluded. This is the main advantage of this drug.

However, this drug also has disadvantages. Doctors say that the drug can provoke a large number of adverse reactions. The main disadvantage that scares women - a set of overweight. In addition, the drug has a negative effect on the skin - rashes of acne and blackheads appear very often. Another negative characteristic is a rather extensive list of contraindications.

Reviews of "Belara"

Both gynecologists and patients report that Belara copes with its main task - the prevention of an unwanted pregnancy. However, against the background of its intake, as noted by the vast majority of women, a huge number of side effects develop, such as weight gain, skin problems, menstrual disorders (absence of menstruation or their duration). Gynecologists claim that all such negative effects disappear after the body gets used to the dosage of the hormone entering the body. However, women prefer not to take the drug if they see that the body reacts negatively, and ask the doctor to choose a replacement.

We reviewed the reviews of the "Belara" and instructions.

Pharmacodynamics and pharmacokinetics

Pharmacodynamics

The combined drug for contraception, taken orally.

Prolonged use of the drug leads to a decrease in secretion. follicle-stimulating hormone and lutenizing hormoneand, consequently, to suppress the process of ovulation. At the same time, proliferation and secretory transformation take place. endometriumimpeding the fixation of a fertilized egg. Viscosity of mucous secretions from the cervix increases, which passes with difficulty in passing male germ cells through the cervical canal and inhibiting their mobility.

Acetate included in the preparation chlormadinone is an progestinwith anti-androgenic properties. Its effect is based on the ability to compete with androgens in specific receptors, weakening the effect androgen. Pearl Index (the probability of getting pregnant in 12 months) varies between 0.291–0.698 and depends on the thoroughness of the woman’s admission regimen.

Approximately 1.7 mg acetate is required to completely block ovulation. chlormadinone daily. The required dosage per cycle is 25 mg.

Pharmacokinetics

Chlormadinone Acetate. Quickly and completely absorbed. The maximum concentration occurs one and a half hours. 95% binds to human blood proteins, mainly albumin.

In the process of transformation, many metabolites are formed, the main of which are 3 beta and 3-alpha-hydroxy-chlormadinone acetate.

The average half-life of blood is 34 hours. Chlormadinone Acetate and its metabolites are excreted in approximately equal amounts with urine and through the intestines.

Ethinyl estradiol. Quickly and almost completely absorbed from the intestine, reaching maximum plasma concentration in one and a half hours. Absolute bioavailability is about 40%.

About 98% of the substance is bound to blood proteins. Ethinyl Estradiol transformed by hydroxylation of an aromatic ring. The main derivative is 2-hydroxy-ethinyl estradiol.

Mean half-life ethinyl estradiolof blood is 13 hours. Excreted by the kidneys and with feces in the proportion of 2: 3.

Side effects

  • Reactions from psyche: nervousness, depressed mood, irritability, weakening libido.
  • Reactions from immunity: hypersensitivity to the components of the drug.
  • Reactions from metabolism: changes in the fat composition of the blood, increased appetite.
  • Reactions from nervous system: migraine pain, dizziness.
  • Reactions from sense organs: intolerance to contact lenses, conjunctivitis, visual disturbances, hearing loss, tinnitus.
  • Reactions from circulatory system: pressure increase, arterial hypotension, arterial hypertension, varicose disease, collapse, vein thrombosis.
  • Reactions from digestive systems: flatulence, nausea, vomiting, abdominal pain, diarrhea.
  • Reactions from skin: acne, chloasma, pigmentation disorders, hair loss, hyperhidrosisdry skin urticaria, erythema, eczema, itch, hypertrichosis, erythema nodosum.
  • Reactions from musculoskeletal system: feeling of heaviness lumbodynia, muscle disorders.
  • Reactions from genitourinary system: dysmenorrhea, increased vaginal discharge, amenorrhea, lower abdominal pain, breast fibroadenoma, galactorrhea, vaginal candidiasis, menorrhagia, vulvovaginitis, premenstrual syndrome.
  • General reactions: swelling, fatigue, weight gain.

When applying Belara were also identified the following side effects:

  • increased risk of biliary tract diseases,
  • increased risk arterial and venous thromboembolism,
  • increased risk of benign tumors in the liver, in rare cases may develop intraperitoneal bleeding,
  • exacerbation of chronic inflammatory bowel disease.

Belara, instructions for use (method and dosage)

Instructions for use Belara prescribes to take birth control pills inside. They should be removed from the blister and swallowed whole, if necessary, drinking a small amount of liquid. The pill should be consumed every day at the same time (preferably in the evening) for 21 days in a row, then you should stop taking it for 7 days, approximately 2-4 days after consuming the last pill, withdrawal bleeding similar to menstrual flow develops.

After the completion of the 7-day break, it is necessary to begin using the drug from the next pack, regardless of whether the bleeding has stopped.

The first pill must be drunk on the first day of the woman’s physiological cycle (the first day of the next menstruation). In this case, the contraceptive effect begins with the first day of reception and lasts for a week break in reception.

The first pill can be drunk at 1-5 days of menstrual bleeding (no matter whether the bleeding stopped or not). In this case, during the first seven days of intake, you should also use barrier methods of contraception.

If menstrual bleeding appeared more than 5 days ago, it is recommended to wait for the start of the next menstruation, and then proceed to the cycle of taking the drug.

The transition from a different hormonal contraceptive (combined) to Belara

Switch with products containing 21-22 tablets. It is necessary to finish using all the tablets from the previous packaging. Next, the first tablet of Belara must be drunk the next day. There should be no interruption in the use of pills, and the woman is not advised of the onset of the next menstruation. Additional methods of contraception in this case are not required.

Transition from products containing one progestogen (mini drank)

In this case, the first tablet of Belara should be drunk on the following day after using the last tablet, which includes only the gestagen. During the first seven days it is recommended to use barrier methods of contraception.

Transition from hormonal contraceptives injectable or implant

Reception of Belara can be started on the first day of the implant removal or on the first day of the scheduled injection. During the first seven days, it is advised to use barrier contraceptive methods.

After abortion (spontaneous or medical) in the first 3 months of pregnancy

Using Belara can start on the day of abortion. In this case, you can not apply additional ways to prevent pregnancy.

After childbirth or abortion (spontaneous or medical) at 3-6 months of pregnancy

Reception of Belara is recommended to start in the fourth week after childbirth, if lactation is not performed, or after an abortion in the second trimester of pregnancy. In this case, it is not necessary to use additional methods of contraception.

If the use of the drug started after the fourth week after childbirth or abortion, it is recommended to use additional methods of contraception during the first week.

If there was already sexual intercourse, it is advisable to exclude pregnancy or wait for the next menstrual cycle before taking the drug.

If a woman forgot to take a pill, but took it after 12 hours, the contraceptive effect may be weakened.

If the pill was missed, then follow the rules below:

  • do not stop taking the medicine for more than a week,
  • 7 days of continuous medication is necessary to achieve confident suppression of the regulation of the hypothalamus-pituitary-ovaries system.

The missed pill is advised to take immediately, even if it means that you need to take two pills at a time. Then follow the standard scheme. During the next week, you need to use barrier methods of contraception.

If there are less than seven pills left in the pack, immediately after using the pills from this pack, you should start using the pills from the new pack - there should be no break between the packs. Cancellation bleeding usually does not occur until all the tablets from the second pack are used, however exceptions are possible. If the withdrawal bleeding does not appear after the end of the cycle of the second package, then you need to perform pregnancy test.

Interaction

The following substances may lower concentration. ethinyl estradiol in the blood and weaken contraceptive activity:

  • all drugs that increase intestinal motility or inhibit absorption,
  • substances that activate microsomal liver enzymes, such as Rifabutin, Rifampicin, barbiturates, Griseofulvin, anticonvulsants, Barbecaclon, Modafinil, protease inhibitors, Primidon, drugs Hypericum,
  • a number of antibiotics (for example, Tetracycline, Ampicillin).

With the simultaneous use of such drugs, it is necessary to apply additional barrier methods of contraception during therapy and within a week after it. When taking substances that lower the concentration ethinyl estradiol in the blood due to the activation of microsomal liver enzymes, additional barrier methods should be used within four weeks after the end of therapy.

The following substances may increase the concentration ethinyl estradiol in blood:

Analogs of Belara

Coincides according to indications

Price from 243 rubles. Analogue cheaper by 367 rubles

Coincides according to indications

Price from 265 rubles. Analogue cheaper by 345 rubles

Coincides according to indications

Price from 269 rubles. Analogue cheaper by 341 rubles

Coincides according to indications

Price from 294 rubles. Analogue cheaper by 316 rubles

Coincides according to indications

Price from 342 rubles. Analogue cheaper by 268 rubles

Coincides according to indications

Price from 356 rubles. Analogue cheaper by 254 rubles

Coincides according to indications

Price from 382 rubles. Analogue cheaper by 228 rubles

Coincides according to indications

Price from 395 rubles. Analogue cheaper by 215 rubles

Coincides according to indications

Price from 402 rubles. Analogue cheaper by 208 rubles

Coincides according to indications

Price from 428 rubles. Analogue cheaper by 182 rubles

Coincides according to indications

Price from 430 rubles. Analogue cheaper by 180 rubles

Coincides according to indications

Price from 458 rubles. Analogue cheaper by 152 rubles

Coincides according to indications

Price from 529 rubles. Analogue cheaper by 81 rubles

Coincides according to indications

Price from 536 rubles. Analogue cheaper by 74 rubles

Coincides according to indications

Price from 541 rubles. Analogue cheaper by 69 rubles

Coincides according to indications

Price from 584 rubles. Analogue cheaper by 26 rubles

Coincides according to indications

Price from 590 rubles. Analogue cheaper by 20 rubles

Coincides according to indications

Price from 595 rubles. Analogue cheaper by 15 rubles

Coincides according to indications

Price from 598 rubles. Analogue cheaper by 12 rubles

Coincides according to indications

Price from 676 rubles. Analog more expensive at 66 rubles

Coincides according to indications

Price from 699 rubles. Analog more expensive at 89 rubles

Coincides according to indications

Price from 753 rubles. Analog more by 143 rubles

Coincides according to indications

Price from 758 rubles. Analog more expensive by 148 rubles

Coincides according to indications

Price from 958 rubles. Analog more expensive at 348 rubles

Coincides according to indications

Price from 960 rubles. Analog more expensive at 350 rubles

Coincides according to indications

Price from 978 rubles. Analog is more expensive at 368 rubles

Coincides according to indications

Price from 979 rubles. Analog more expensive at 369 rubles

Coincides according to indications

The price is from 1029 rubles. Analog more expensive at 419 rubles

Coincides according to indications

Price from 1140 rubles. Analog more expensive by 530 rubles

Coincides according to indications

The price is from 1298 rubles. Analog more by 688 rubles

Coincides according to indications

Price from 1343 rubles. Analog more expensive at 733 rubles

Coincides according to indications

Price from 3017 rubles. Analog more expensive by 2407 rubles

Contraceptive "Belara": instructions for use, reviews

The drug belongs to the group of oral monophasic contraceptives that reduce the high content of male hormones in the blood. Regular intake of tablets leads to a temporary suppression of ovulation and changes in the structure of the endometrium. Natural mucus at the entrance to the uterus acquires density and viscosity, making it difficult for sperm to pass.

Pink tablets are available in a transparent blister. One pack of the drug contains 21 tablets, which a woman should take within a month with a seven-day break. Ethinyl estradiol (30 µg), chlormadinone (2 mg), and additional components are included in the composition of one tablet.

Pharmacological properties

The drug is not only a reliable means of protection, it positively affects the well-being of a woman, normalizes hormonal disruptions and suspends some abnormal processes occurring in the female body.

Some patients with chronic inflammatory diseases of the urogenital system are recommended to take Belara hormone pills regularly. Reviews of doctors who prescribe this contraceptive to women, contain constructive information about the positive effect of the drug on the body, namely:

  • normalization of the menstrual cycle occurs,
  • pains and the poor state of health of the woman in the premenstrual period are reduced,
  • the risk of anemia is reduced,
  • decreases the likelihood of dangerous malignant tumors in the endometrium, ovaries,
  • inflammatory processes of the reproductive system are prevented,
  • unwanted pregnancy is completely excluded.

Regimen

The drug is taken on the first day of the menstrual cycle. The tablet should not be chewed, but just drink it with a small portion of plain water. The drug is taken for 21 days, daily. In the first week of admission, it is recommended to use additional contraception.

After this period, you should take a break for 7 days, during which menstruation begins. The next package must be opened on the eighth day, regardless of whether the bleeding has stopped.

If other contraceptives were used previously

In general, women do not have additional questions about the Belara drug regimen. Reviews of girls who used these birth control pills for the first time, talk about their effectiveness, availability and ease of use. However, you should carefully read the instructions if you are going to change the contraceptive.

The regimen of the drug in special cases:

  • If it is intended to switch from a contraceptive comprising from 21 to 28 tablets, you need to finish the old package and eliminate the break for menstrual bleeding. It is better to take the initial pill from the new package the next day. In this case, the use of additional contraception is not required.
  • When switching from progestin contraceptives (mainly mini-pills) or hormonal injections, the pill should be started immediately, without interruption. However, in these cases, it is recommended to use barrier contraception for a week after changing the drug.

Taking the pill in the postpartum period

After the transferred abortion, it is recommended to start using the contraceptive "Belara" immediately. In the postpartum period, a woman who does not feed the baby with breast milk can start taking the drug on days 22-28.

If before this period of sexual contact was not, additional contraception should not be used. If after birth more than 28 days have passed, you should open a new blister, but in the first week use additional measures for protection. If before the start of taking the pills there was sexual contact, you should wait for the menstrual period, precluding pregnancy, and start taking the drug in the usual way.

Possible use

With caution and after additional examination the drug "Belara" is assigned to patients with such diagnoses:

  • obesity,
  • kidney or heart failure
  • tetany (convulsions),
  • bronchial asthma,
  • mastopathy,
  • multiple sclerosis,
  • autoimmune diseases
  • inflammatory bowel disease.

Mostly women were satisfied with taking Belara contraceptives. Reviews of the drug were positive. Some of the women had small spot bleeding, especially in the first month of use, but over time they stopped on their own.

Side effects

Most of the girls had headaches and minor discomforts at the start of taking Belara contraceptive pills. Reviews of women who systematically took this drug, allow us to conclude that it is an excellent contraceptive and has minor side effects, which eventually pass completely.

The initial period of intake of drugs could be accompanied by skin rashes, irritability, increased appetite and vaginal secretions. Some women had a feeling of heaviness and nausea. However, these symptoms stopped very quickly and disappeared without a trace.

Contraceptives hormonal "Belara": reviews

The drug is a modern, reliable means to prevent unwanted pregnancy. However, it should take into account some of the nuances that may arise during the reception of contraceptive "Belara". Reviews of women who have used the drug for a long time are mostly positive.

Systematic contraceptive pill relieves heavy menstrual pain, even cures acne. For some patients, this drug was prescribed by a doctor as an effective treatment for polycystic ovary.

However, you should be aware that if vomiting or diarrhea occurred while taking birth control pills, additional contraception is recommended.

Important features

If you decide to resort to oral contraception, you should not forget about a regular regimen and take a pill in time.

If the drug was not consumed in due time, you need to drink dragee for 12 hours. Further contraceptive intake should be carried out in the usual way. If more than 12 hours have passed, you can drink 2 pills, but during the next week it is recommended to use additional contraception.

According to women, the drug "Belara" is a reliable means of protection from unplanned pregnancy, regular use of which relieves pain during the menstrual cycle, relieves acne, and also has a beneficial effect on the overall condition of the body.

Use during pregnancy and during breastfeeding

Pregnancy: the use of the drug Belara ® during pregnancy is contraindicated. Before you start using the drug Belara ®, it is necessary to exclude the presence of pregnancy. When pregnancy occurs while taking the drug Belara ®, the drug should be immediately discontinued. Existing epidemiological data do not contain information about the development of teratogenic or embryotoxic effects in women who accidentally took drugs during pregnancy that contain estrogens and gestagens in the same combination as in Belara®.
Breastfeeding period: use of Belara ® is contraindicated during breastfeeding, since the drug reduces the amount of milk produced and changes its composition. Small amounts of hormones that are part of the contraceptive and / or their metabolites pass into breast milk and can affect the baby.

special instructions

Smoking
Smoking increases the risk of serious cardiovascular complications associated with taking combined oral contraceptives (COCs). The risk increases with age, with an increase in the number of cigarettes smoked and is high in women over 35 years of age. Smokers over the age of 35 should use other methods of contraception.
The use of COCs is associated with an increased risk of various serious diseases, such as myocardial infarction, thromboembolism, stroke or liver tumors. Other risk factors such as hypertension, hyperlipidemia, obesity and diabetes significantly increase the risk of complications and mortality.
If you have one of the following diseases / risk factors, you should weigh the potential risk and the expected benefits of using Belara ®, and discuss this with a woman before she starts taking this drug. If these diseases or risk factors arise or progress during the use of the drug, the patient should consult with your doctor. The physician must decide whether to continue or discontinue treatment.
Thromboembolism or other vascular diseases
The results of epidemiological studies show that there is a relationship between taking oral contraceptives and increasing the risk of venous and arterial thromboembolic diseases, for example, myocardial infarction, cerebral hemorrhage, deep venous thrombosis and pulmonary thromboembolism. These diseases rarely develop.
The use of combined oral contraceptives (COCs) entails a higher risk of venous thromboembolism (VTE) than in abstaining from taking them. This risk of VTE is highest in women during the first year of combined oral contraceptive use. This risk is less than the risk of VTE associated with pregnancy, which is 60 cases per 100,000 pregnancies, VTE leads to death in 1-2% of cases.
It is not known how taking Belara ® affects the risk of VTE compared with other combined oral contraceptives.
The risk of venous thromboembolism in women taking COCs increases in the following cases:

  • With age.
  • If there is a genetic predisposition (for example, venous thromboembolism in brothers and sisters or parents at a relatively young age).
    If there is suspicion of a hereditary predisposition, a woman should be referred to a specialist for an appointment before making a decision on taking COC.
  • With prolonged immobilization.
  • With obesity (body mass index more than 30 kg / m 2).
The risk of arterial thromboembolism increases in the following cases:
  • With age.
  • Smoking.
  • Dyslipoproteinemia.
  • Obesity (body mass index more than 30 kg / m 2).
  • Arterial hypertension.
  • Heart valve disease.
  • Atrial fibrillation.
  • Presence of hereditary predisposition (for example, arterial thromboembolism in siblings or parents at a relatively young age).
If there is suspicion of a hereditary predisposition, a woman should be referred to a specialist for an appointment before making a decision on taking COC.
Other diseases that affect blood circulation are diabetes mellitus, systemic lupus erythematosus, hemolytic uremic syndrome, chronic inflammatory bowel disease (Crohn's disease and ulcerative colitis), and sickle cell anemia.
When evaluating the benefit / risk ratio of the drug, it should be remembered that adequate treatment of the above diseases can reduce the risk of thrombosis.
It should also be borne in mind that the risk of thromboembolic complications increases in the postpartum period.
There is no consensus on whether there is a relationship between superficial thrombophlebitis and / or varicose veins and the etiology of venous thromboembolism.
Possible symptoms of venous and arterial thrombosis are as follows:
  • pain and / or swelling in the lower limb,
  • sudden severe chest pain, regardless of whether it gives to the left hand or not,
  • sudden dyspnea, sudden cough for an unknown reason,
  • unexpectedly strong and prolonged headache
  • partial or complete loss of vision, diplopia / speech disorders or aphasia,
  • dizziness, fainting, in some cases including focal epileptic seizures,
  • sudden weakness or sensitivity disorders in one side of the body or part of the body,
  • movement disorders
  • acute abdominal pain.
Patients taking Belara ® should be informed that they should see a doctor if they have any possible symptoms of thrombosis. If you suspect or confirm thrombosis, taking the drug Belara ® should be discontinued. An increase in the frequency and intensity of migraine attacks on the background of the use of the drug Belara ® may indicate a prodromal phase of the blood supply to the brain and may be an indication for an immediate cessation of the drug.
Tumors
Some epidemiological studies indicate that long-term use of oral contraceptives is a risk factor for developing cervical cancer in women infected with the human papillomavirus (HPV). However, this issue is controversial, since it is unclear to what extent other factors influence the results obtained (for example, differences in the number of sexual partners or the use of barrier methods of contraception).
The relative risk of developing breast cancer is somewhat higher in women taking COCs (relative risk (RR) = 1.24), but gradually decreases over 10 years after stopping COCs. However, a causal relationship between the disease and the drug is not established. The observed increased risk may be explained by the fact that women taking COCs are diagnosed with breast cancer at an earlier stage than those who do not use them, as well as the biological effect of COC or a combination of both factors.
In rare cases, after taking COCs, cases of benign liver tumors were recorded, and malignant tumors were recorded even less frequently. In some cases, these tumors can cause life-threatening intra-abdominal bleeding. In case of severe abdominal pain that does not disappear on its own, an enlarged liver or signs of intra-abdominal bleeding, the likelihood of developing a liver tumor should be considered and the use of Belara ® should be stopped.
Other diseases
Many women taking oral contraceptives have a slight increase in blood pressure. A clinically significant increase in blood pressure is rarely observed. The relationship between oral contraceptive use and arterial hypertension with clinical manifestations has not yet been confirmed. If against the background of taking the drug Belara ® there is a clinically significant increase in blood pressure, then you should stop taking the drug and treat hypertension. As soon as the blood pressure indicators are normalized after antihypertensive therapy, the administration of the drug Belara ® can be continued.
In women with a history of pregnant herpes, while taking COCs, a relapse of this disease is possible. Women with a history or a family history of whom have indications of hypertriglyceridemia in patients receiving COCs, increase the risk of developing pancreatitis. In case of acute or chronic liver dysfunction, it may be necessary to stop taking COCs before normalizing liver function. When recurrent cholestatic jaundice, first diagnosed during pregnancy or taking sex hormones, you must stop taking COCs.
Taking COCs may affect peripheral insulin resistance or glucose tolerance. Therefore, patients with diabetes and taking oral contraceptives should be carefully monitored.
In rare cases, chloasma may occur, especially in women with a history of chloasma in pregnant women. Women who are predisposed to chloasma should avoid exposure to the sun, as well as ultraviolet radiation while taking oral contraceptives.
Belara ® is contraindicated in patients with rare hereditary intolerance to galactose, lactase deficiency or glucose-galactose malabsorption.
Precautionary measures
Taking drugs containing estrogen or estrogen / progestogen can adversely affect certain diseases and conditions. In the following cases, careful medical observation is necessary:
  • epilepsy,
  • multiple sclerosis,
  • tetany,
  • migraine,
  • asthma,
  • heart or kidney failure
  • chorea,
  • diabetes,
  • liver disease,
  • dyslipoproteinemia,
  • autoimmune diseases (including systemic lupus erythematosus),
  • obesity,
  • arterial hypertension,
  • endometriosis,
  • phlebeurysm,
  • thrombophlebitis,
  • bleeding disorders,
  • mastopathy,
  • uterine fibroids,
  • herpes pregnant
  • depression,
  • chronic inflammatory bowel disease (Crohn's disease, ulcerative colitis).

Medical examination
Before the appointment of the drug Belara ® should conduct a medical examination and collect a complete family and personal history of the patient in order to identify contraindications and risk factors. When taking the drug Belara ® this procedure must be repeated 1 time in six months. Regular medical examinations are also necessary because contraindications (for example, a transient ischemic attack) or risk factors (for example, a personal or family history of venous or arterial thrombosis) may first appear against the background of oral contraceptives. Medical examination should include measurement of blood pressure, examination of the mammary glands, abdominal organs, internal and external genital organs, including cytological examination of the cervical epithelium, and the performance of appropriate laboratory tests.
The woman should be informed that taking oral contraceptives, including Belara ®, does not protect against HIV infection (AIDS), as well as from other sexually transmitted diseases.
Laboratory research
Some laboratory tests may change due to COC use, for example, liver, thyroid, adrenal gland, plasma protein proteins (for example, sex hormone-binding globulin (GSPH), lipoproteins), as well as carbohydrate metabolism, coagulation and fibrinolysis. The nature and extent of changes in laboratory parameters depend on what hormones are prescribed and in what doses.
Reduced efficiency
Missed use of a film-coated tablet, vomiting, or intestinal disorders, including diarrhea, prolonged use of certain concomitant medications, or, in very rare cases, metabolic disorders, may decrease the contraceptive efficacy of Belara ®.
Impact on the control of the menstrual cycle

  • "Breakthrough" bleeding and minor bleeding.
The use of all oral contraceptives can lead to vaginal bleeding (breakthrough bleeding and minor bleeding), especially during the first cycles of the drug. Therefore, a medical evaluation of irregular cycles should be carried out only after a period of adaptation equal to the first three cycles. If during the treatment with the drug Belara ®, "breakthrough" bleeding is constantly observed or appears for the first time, although the cycle was previously regular, an examination should be carried out to prevent pregnancy or organic diseases. After exclusion of pregnancy or organic disease, you can continue taking the drug Belara ® or switch to the use of another drug. Acyclic bleeding can be a sign of a decrease in contraceptive efficacy.
No "withdrawal" bleeding
As a rule, after 21 days of taking the drug, there is a "withdrawal" bleeding. Sometimes, especially during the first months of taking the drug, there can be no "withdrawal" bleeding. However, this does not necessarily mean a decrease in the contraceptive effect. If there was no bleeding after one cycle of treatment, during which the patient did not forget to take Belara ®, the 7-day pause was not extended, the patient did not have vomiting or diarrhea, pregnancy was unlikely and Belara ® could be continued. If, prior to the first absence of "withdrawal" bleeding, taking Belara ® occurred with a violation of instructions or there was no "withdrawal" bleeding, it was observed for two cycles, then it is necessary to exclude pregnancy before continuing to take the drug.
Together with the drug Belara ® should not take herbal medicines containing St. John's wort (Hypericum perforatum).

Influence on ability to drive vehicles and mechanisms

Description, composition, shape, packaging

The drug "Belara" goes on sale in the form of round biconvex light pink tablets with a white core. It contains active ingredients such as chlormadinone acetate and ethinyl estradiol. It also contains additional ingredients in the form of lactose monohydrate, povidone, cornstarch and magnesium stearate.

As for the pink film shell, it consists of titanium dioxide, talc, hypromellose, lactose monohydrate, macrogol 6000, propylene glycol and a dye of red iron oxide.

In the sale of the medium in question comes in blisters, which are contained in a box of cardboard.

How to drink Belara contraceptive pills?

According to the instructions, birth control pills should be taken orally, without chewing and washing down with a small amount of water. How should receive? "Belara" must be taken daily at the same time (in the evening).

The duration of the drug is 21 days. Next, it must be interrupted for a week. About 2-4 days after the last pill, menstrual bleeding is observed.

After seven days, it is required to start taking the drug from another pack, regardless of whether the bleeding has stopped or not.

The first pill should be used on the 1st day of the physiological cycle (that is, on the first day of the next menstruation). Only in this case, contraception begins its action and lasts even during a week break.

However, the first tablet can be taken for 2-5 days of the menstrual cycle. In this case, during the first 7 days, you should use barrier methods of contraception.

If menstruation began more than 5 days ago, then it is necessary to wait for the start of the next one, and only then proceed to the cycle of taking pills.

Can Belara contraceptives be combined with other drugs? Using these tablets with others may weaken their effect. These overwhelming drugs include:

  • substances that activate microsomal liver enzymes,
  • intestinal motility enhancers,
  • some antibiotics.

After the “Belara” and the receipt of these funds should use additional methods of contraception.

Price and analogues

The price of Belara in pharmacies in Russia (21 tablets per pack) is 491-536 rubles. The price of tablets number 63 starts from 710 rubles.

Buy such contraceptive pills number 21 in Ukraine will cost 250-650 hryvnia, and the minimum cost of packing number 61 will be 910 hryvnia.

Analogs of this drug are the following: “Vidora”, “Daila”, “Jess”, “Difenda”, “Zhanin”, “Lindinet 20”, “Logest”, “Mersilon”, “Milanda”, “Model Tin”, “Novinet” ”,“ Silest ”,“ Femoden ”,“ Yarina Plus ”.

As for the price, it directly depends on the number of tablets per pack. The average cost of the drug "Belara" is 490-530 rubles (21 pcs.).

Belara doctor reviews

Belara

Belara - combination drug for contraception. With prolonged use leads to the suppression of the process of ovulation. The proliferation and secretory transformation of the endometrium prevents the formation of a fertilized egg. The formation of mucous secretions from the cervix occurs, which leads to difficulty in penetration of spermatozoa.

It is necessary to take the drug with caution with diseases of the respiratory system, diabetes, endometriosis, tumors, hypertension.

In practice, patients note side effects such as: decreased libido, increased appetite, nausea.

The drug has established itself as a reliable means of contraception. But use it only as directed by the doctor.

Contraceptive with androgenic effect

Belara is a modern reliable means for oral contraception. When conducting research, pregnancy occurred in an extremely small number of women, and more than half of the pregnancies were associated with a violation of the rules for taking oral contraceptives during the ovulation period.

In addition to a very strong contraceptive effect, Belara has a powerful anti-androgenic property. The drug has been successfully used to treat acne, seborrhea, excessive hairiness in women.

But, despite a lot of positive effects, Belara is primarily a hormonal agent. Therefore, given the list of side effects and contraindications, only a gynecologist on full-time admission can prescribe this drug.

Belara

Belara belongs to the group of monophasic oral contraceptives, which also has a pronounced antiandrogenic effect. It contains a combination of ethinyl estradiol and chlormadinone.
Regular intake leads to the suppression of ovulation and natural cyclic changes in the endometrium.
Antiandrogenna action - a decrease in the level of testosterone in the blood. With a constant reception of Belara, the intensity of hair on the legs, abdomen, face is reduced, sweating is reduced and skin condition improves. Manifestations of acne become less pronounced and gradually disappear completely.
Also, this drug is used to normalize the menstrual cycle. The cycle becomes regular and painless. The risk of cancer and inflammatory diseases of the reproductive organs is reduced, and also prevents ectopic (ectopic) pregnancies.

Belara

Belara is a combined oral contraceptive drug.

Like all COCs, in its action, Belar reduces the production of LH and FSH hormones, thereby suppressing ovulation, has an effect on the endometrium, preventing the fertilized egg from nidatsii, increases the viscosity of the mucous component of the cervical canal, which limits the passage of sperm through the cervix and reduces mobility.

The acetate that is part of gestagen - chlormadinone has a pronounced antiandrogenic effect, therefore Belara is one of the drugs of choice for young women with skin symptoms of hyperandrogenism (seborrhea, acne, hirsutism, alopecia), facilitates the course of premenstrual syndrome, provides reliable control of the cycle. An important advantage is the affordable price, the drug is available both in standard packaging and in the amount of 63 tablets (3 menstrual cycles), which reduces the cost of the drug and allows you to save.

During the multicenter study of the KOC "Belara" it was revealed that the drug has no clinically significant effect on the overall hemostatic balance, body weight, mood and libido.

Belara is an example of a good drug with control of the ovarian-menstrual cycle, a pronounced anti-androgenic effect, a drug that not only protects from unwanted pregnancy, abortion and its complications, but also gives an excellent cosmetic effect. I rarely see side effects in my clinical practice.

Pin
Send
Share
Send
Send